Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) CEO Vishwas Seshadri bought 10,000 shares of Abeona Therapeutics stock in a transaction dated Thursday, April 25th. The stock was purchased at an average price of $3.20 per share, for a total transaction of $32,000.00. Following the purchase, the chief executive officer now directly owns 538,260 shares […]
Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) CEO Vishwas Seshadri acquired 10,000 shares of the stock in a transaction dated Thursday, April 25th. The shares were bought at an average cost of $3.20 per share, with a total value of $32,000.00. Following the completion of the transaction, the chief executive officer now owns 538,260 […]
StockNews.com cut shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. Abeona Therapeutics Price Performance NASDAQ ABEO opened at $3.26 on Tuesday. Abeona Therapeutics has a fifty-two week low of $2.83 and a fifty-two week high of $9.01. […]
Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) CFO Joseph Walter Vazzano purchased 5,608 shares of the stock in a transaction on Thursday, April 25th. The stock was acquired at an average cost of $3.14 per share, for a total transaction of $17,609.12. Following the acquisition, the chief financial officer now directly owns 233,868 shares […]
StockNews.com upgraded shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a sell rating to a hold rating in a research report report published on Monday morning. Abeona Therapeutics Price Performance NASDAQ ABEO opened at $7.53 on Monday. The stock has a market capitalization of $205.95 million, a price-to-earnings ratio of -2.92 and a beta […]